Literature DB >> 16598385

Effect of monoterpenes on the formation and activation of osteoclasts in vitro.

Silvia Dolder1, Willy Hofstetter, Antoinette Wetterwald, Roman C Mühlbauer, Rolf Felix.   

Abstract

UNLABELLED: Monoterpenes, present in aromatic plants, are known to inhibit bone resorption in vivo. In this in vitro study, they inhibited the activation of osteoclasts only at high concentrations but inhibited the formation at much lower concentrations. Therefore, monoterpenes may act in vivo directly on osteoclastogenesis.
INTRODUCTION: Monoterpenes are the major components of essential oils, which are formed in many plants. Typically, they are found in herbs and certain fruits. When fed to rats, they inhibit bone resorption by an unknown mechanism. In this study, their effect on the activity and formation of osteoclasts in vitro was studied.
MATERIALS AND METHODS: The effect of monoterpenes on the development of osteoclasts was studied in co-cultures of bone marrow cells and osteoblasts and in cultures of spleen cells grown with colony stimulating factor (CSF)-1 and RANKL. In cultures of primary osteoblasts, alkaline phosphatase activity and levels of mRNA encoding RANKL and osteoprotegerin (OPG) mRNA (RT-PCR), and in osteoblast and spleen cell cultures, lactate dehydrogenase activity, a measure of toxicity, were determined. The activity of isolated rat osteoclasts was determined by counting the osteoclasts with actin rings using histofluorometry.
RESULTS: The monoterpenes inhibited the formation of osteoclasts more strongly in co-cultures (> or = 1 microM) than in cultures of spleen cells (> or = 10 microM). They had a minor effect on osteoblasts. Toxic effects were not observed. The inhibition of the formation of osteoclasts was not reversed by the addition of farnesol and geranylgeraniol, excluding an effect of the monoterpenes through the mevalonate pathway. A high concentration of 1 mM was required to inhibit the activation of osteoclasts. This effect, shown for menthol and borneol, was reversible.
CONCLUSIONS: The results suggest that the monoterpenes inhibit bone resorption in vivo through a direct effect on the formation of osteoclasts acting mainly on the hemopoietic cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16598385     DOI: 10.1359/jbmr.060111

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  6 in total

1.  Bisphosphonates inhibit cell functions of HUVECs, fibroblasts and osteogenic cells via inhibition of protein geranylgeranylation.

Authors:  Nadine Hagelauer; Thomas Ziebart; Andreas M Pabst; Christian Walter
Journal:  Clin Oral Investig       Date:  2014-09-27       Impact factor: 3.573

2.  Cyclic monoterpene mediated modulations of Arabidopsis thaliana phenotype: effects on the cytoskeleton and on the expression of selected genes.

Authors:  Bettina Kriegs; Marcus Jansen; Ka Hahn; Helga Peisker; Olga Samajová; Martina Beck; Silvia Braun; Andreas Ulbrich; František Baluška; Margot Schulz
Journal:  Plant Signal Behav       Date:  2010-07-01

3.  Antibacterial effect of the combination of terpenoids.

Authors:  Takayoshi Yamaguchi
Journal:  Arch Microbiol       Date:  2022-07-25       Impact factor: 2.667

4.  Antimicrobial activity of synthetic bornyl benzoates against Trypanosoma cruzi.

Authors:  P R C Corrêa; R R S Miranda; L P Duarte; G D F Silva; S A Vieira Filho; A A Okuma; F Carazza; J A Morgado-Díaz; P Pinge-Filho; L M Yamauchi; C V Nakamura; S F Yamada-Ogatta
Journal:  Pathog Glob Health       Date:  2012-05       Impact factor: 2.894

5.  Redox-Dependent Bone Alkaline Phosphatase Dysfunction Drives Part of the Complex Bone Phenotype in Mice Deficient for Memo1.

Authors:  Matthias B Moor; Suresh K Ramakrishnan; Finola Legrand; Silvia Dolder; Mark Siegrist; Fanny Durussel; Gabriel Centeno; Dmitri Firsov; Nancy E Hynes; Willy Hofstetter; Olivier Bonny
Journal:  JBMR Plus       Date:  2018-01-17

6.  Sodium-dependent phosphate transporters in osteoclast differentiation and function.

Authors:  Giuseppe Albano; Matthias Moor; Silvia Dolder; Mark Siegrist; Carsten A Wagner; Jürg Biber; Nati Hernando; Willy Hofstetter; Olivier Bonny; Daniel G Fuster
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.